Art

J-GLOBAL ID：201602286961583990   Reference number：16A1175922

Prognosis of metastatic renal cell carcinoma with first-line interferon-α therapy in the era of molecular-targeted therapy

分子標的化治療時代に於ける第1選択インターフェロンα治療による転移性腎細胞癌の予後

Author (16)： Kawano Yoshiaki (Department of Urology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan) ,  Takahashi Wataru (Department of Urology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan) ,  Eto Masatoshi (Department of Urology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan) ,  Eto Masatoshi (Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan) ,  Kamba Tomomi (Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan) ,  Miyake Hideaki (Division of Urology, Department of Surgery Related, Kobe University Graduate School of Medicine, Kobe, Japan) ,  Fujisawa Masato (Division of Urology, Department of Surgery Related, Kobe University Graduate School of Medicine, Kobe, Japan) ,  Kamai Takao (Department of Urology, Dokkyo Medical University, Shimotsuka- gun, Tochigi, Japan) ,  Uemura Hirotsugu (Department of Urology, Kinki University School of Medicine, Osaka-Sayama, Japan) ,  Tsukamoto Taiji (Department of Urologic Surgery and Andrology, Sapporo Medical University School of Medicine, Sapporo, Japan) ,  Azuma Haruhito (Department of Urology, Osaka Medical College, Takatsuki, Japan) ,  Matsubara Akio (Department of Urology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan) ,  Nishimura Kazuo (Department of Urology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan) ,  Nakamura Tsuyoshi (Graduate School of Science and Engineering, Chuo University, Tokyo, Japan) ,  Ogawa Osamu (Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan) ,  Naito Seiji (Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan)
Material： Cancer Science (Web)  (Cancer Sci (Web))
Volume： 107  Issue： 7  Page： 1013-1017  Publication year： 2016 
JST Material Number： U0505A  ISSN： 1349-7006  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Thesaurus term： *molecular target therapy ,...
Semi thesaurus term： *metastatic renal cell carcinoma ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A1175922&from=J-GLOBAL&jstjournalNo=U0505A") }}

Author keywords (5)： The Era of molecular targeted therapy ,  interferon-α ,  overall survival ,  prognostic factors ,  renal cell carcinoma

JST classification (3)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Urogenital tumors(=neoplasms)  (GM04000S) ,  Cytokines  (EB08090G)

Reference (33)：

• Gupta K, Miller JD, Li JZ, Russell MW, Charbonneau C. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev 2008; 34: 193- 205.
• Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49: 1374-403.
• Athar U, Gentile TC. Treatment options for metastatic renal cell carcinoma: a review. Can J Urol 2008; 15: 3954-66.
• Negrier S, Escudier B, Lasset C et al. Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie. N Engl J Med 1998; 338: 1272-8.
• Mickisch GH, Garin A, van Poppel H, de Prijck L, Sylvester R, Group EOfRaToCEG. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 2001; 358: 966-70.

Terms in the title (5)： 分子標的 ,  治療 ,  インターフェロンα ,  転移性腎細胞癌 ,  予後